Search
Prednisolone phosphate
go.drugbank.com/drugs/DB14631ApprovedInvestigationalVet approved[A187463] Prednisolone phosphate was granted FDA Approval on 19 December 1973.[L14144]
Neratinib
go.drugbank.com/drugs/DB11828ApprovedInvestigationalNeratinib was approved in July 2017 for use as an extended adjuvant therapy in Human Epidermal Growth Factor Receptor 2 (HER2) positive breast cancer. Approval was granted to Puma Biotechnology Inc. for the tradename Nerlynx. Neratinib i...
Misoprostol
go.drugbank.com/drugs/DB00929ApprovedInvestigational[A181586] Misoprostol was granted FDA approval on 27 December 1988.[L7616]
Categories: Prostaglandin E1 Analog, Prostaglandins E, SyntheticElagolix
go.drugbank.com/drugs/DB11979ApprovedInvestigationalFood and Drug Administration (FDA) approved AbbVie's elagolix under the brand name Orilissa as the first and only oral gonadotropin-releasing hormone (GnRH) antagonist specifically developed for women … Subsequently, as Orilissa (elagolix) was approved by the FDA under priority review [F815], this expedited new approval gives healthcare professionals another valuable option for treating the potentially
Lisocabtagene maraleucel
go.drugbank.com/drugs/DB16582ApprovedInvestigational[A228493] Lisocabtagene maraleucel was granted FDA approval on 5 February 2021 [L31583] and EC approval on 5 April 2022.[L42210] It was later granted Health Canada approval on 6 May 2022. … [L31588] CAR T-cell therapy has changed the treatment of B-cell lymphomas, significantly increasing survival rates over standard therapy.
Naloxone
go.drugbank.com/drugs/DB01183ApprovedInvestigationalVet approvedThere are over-the-counter nasal sprays available. When injected intramuscularly (IM), naloxone acts within three to five minutes. … [L33714,L33719] Naloxone was granted FDA approval on 13 April 1971.[L33709]
Mixtures: OXYCODON COMP EVER 10/5MG, OXYCODON COMP EVER 10/5MGProducts: NALOKSON HIDROKLORUR ENJ.10AMP(D)(ENylidrin
go.drugbank.com/drugs/DB06152ApprovedWithdrawnThis effect may help to improve memory/judgment, improve walking ability, and support the healing of frostbite/ulcers [L2283]. … Therefore, the FDA has withdrawn nylidrin from the U.S. market [L2286].
Trandolapril
go.drugbank.com/drugs/DB00519ApprovedInvestigationalventricular dysfunction, as an adjunct treatment for congestive heart failure, and to slow the rate of progression of renal disease in hypertensive individuals with diabetes mellitus and microalbuminuria or overt
Mixtures: Trandolapril and Verapamil Hydrochloride ER, Trandolapril and Verapamil Hydrochloride ERTechnetium Tc-99m red blood cells
go.drugbank.com/drugs/DB09493ApprovedWithdrawnRadiolabeled red blood cells are re-injected intravenously into the patient for gamma scintigraphic imaging [FDA Label].
Nalbuphine
go.drugbank.com/drugs/DB00844ApprovedInvestigationalIt appears to be an agonist at kappa opioid receptors and an antagonist or partial agonist at mu opioid receptors.